Lorenzo Tozzi

1.7k total citations
29 papers, 1.0k citations indexed

About

Lorenzo Tozzi is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Lorenzo Tozzi has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Hematology and 9 papers in Molecular Biology. Recurrent topics in Lorenzo Tozzi's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Platelet Disorders and Treatments (7 papers) and Silk-based biomaterials and applications (6 papers). Lorenzo Tozzi is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers), Platelet Disorders and Treatments (7 papers) and Silk-based biomaterials and applications (6 papers). Lorenzo Tozzi collaborates with scholars based in Italy, United States and China. Lorenzo Tozzi's co-authors include Costanza Bogani, David L. Kaplan, Alessandro M. Vannucchi, Alessandra Balduini, Paola Guglielmelli, Alberto Bosi, Christian A. Di Buduo, Niccolò Bartalucci, Serena Martinelli and Alessandro Malara and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Lorenzo Tozzi

28 papers receiving 990 citations

Peers

Lorenzo Tozzi
Duohui Jing Germany
Henk Rozemuller Netherlands
Manfred Bovi Germany
Deborah J. Heath United Kingdom
Kathryn Futrega Australia
Seong‐Jun Choi South Korea
K Stewart United Kingdom
Nunzia Di Maggio Switzerland
Duohui Jing Germany
Lorenzo Tozzi
Citations per year, relative to Lorenzo Tozzi Lorenzo Tozzi (= 1×) peers Duohui Jing

Countries citing papers authored by Lorenzo Tozzi

Since Specialization
Citations

This map shows the geographic impact of Lorenzo Tozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenzo Tozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenzo Tozzi more than expected).

Fields of papers citing papers by Lorenzo Tozzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lorenzo Tozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenzo Tozzi. The network helps show where Lorenzo Tozzi may publish in the future.

Co-authorship network of co-authors of Lorenzo Tozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Lorenzo Tozzi. A scholar is included among the top collaborators of Lorenzo Tozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lorenzo Tozzi. Lorenzo Tozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tozzi, Lorenzo, Giulia Schiroli, Yu Cao, et al.. (2024). In Vivo HSC Gene Editing for Correction of the Sickle Cell Mutation Using RNA Gene Writers. Blood. 144(Supplement 1). 515–515. 3 indexed citations
2.
Martín‐Moldes, Zaira, Lorenzo Tozzi, Margaret J. Duncan, et al.. (2023). Three‐Dimensional Humanized Model of the Periodontal Gingival Pocket to Study Oral Microbiome. Advanced Science. 10(12). e2205473–e2205473. 23 indexed citations
3.
Wu, Limin, Joon Yong Chung, Suzanne E. Hickman, et al.. (2021). Genetic inhibition of RIPK3 ameliorates functional outcome in controlled cortical impact independent of necroptosis. Cell Death and Disease. 12(11). 1064–1064. 18 indexed citations
5.
Tozzi, Lorenzo, Pierre Laurent, Christian A. Di Buduo, et al.. (2018). Multi-channel silk sponge mimicking bone marrow vascular niche for platelet production. Biomaterials. 178. 122–133. 52 indexed citations
6.
Zhu, Zhenghua, Shengjie Ling, Jingjie Yeo, et al.. (2018). High‐Strength, Durable All‐Silk Fibroin Hydrogels with Versatile Processability toward Multifunctional Applications. Advanced Functional Materials. 28(10). 167 indexed citations
7.
Buduo, Christian A. Di, Vittorio Abbonante, Lorenzo Tozzi, David L. Kaplan, & Alessandra Balduini. (2018). Three-Dimensional Tissue Models for Studying Ex Vivo Megakaryocytopoiesis and Platelet Production. Methods in molecular biology. 1812. 177–193. 11 indexed citations
8.
Buduo, Christian A. Di, Lorenzo Tozzi, Stefania Marconi, et al.. (2017). Modular flow chamber for engineering bone marrow architecture and function. Biomaterials. 146. 60–71. 25 indexed citations
9.
Pouli, Dimitra, Lorenzo Tozzi, Carlo Alonzo, et al.. (2017). Label free monitoring of megakaryocytic development and proplatelet formation in vitro. Biomedical Optics Express. 8(10). 4742–4742. 5 indexed citations
10.
Malara, Alessandro, Vittorio Abbonante, Christian A. Di Buduo, et al.. (2015). The secret life of a megakaryocyte: emerging roles in bone marrow homeostasis control. Cellular and Molecular Life Sciences. 72(8). 1517–1536. 62 indexed citations
11.
Bartalucci, Niccolò, Lorenzo Tozzi, Costanza Bogani, et al.. (2013). Co‐targeting the PI3K/ mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms. Journal of Cellular and Molecular Medicine. 17(11). 1385–1396. 77 indexed citations
12.
Bogani, Costanza, Niccolò Bartalucci, Serena Martinelli, et al.. (2013). mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms. PLoS ONE. 8(1). e54826–e54826. 79 indexed citations
13.
Vannucchi, Alessandro M., Niccolò Bartalucci, Costanza Bogani, et al.. (2012). Combined Inhibition of JAK2 and mTOR Signaling Results in Enhanced Efficacy in in-Vitro and Preclinical Mouse Models of JAK2V617F-Driven Myeloproliferative Disease. Blood. 120(21). 708–708. 4 indexed citations
14.
Guglielmelli, Paola, Lorenzo Tozzi, Costanza Bogani, et al.. (2011). Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera. Blood. 117(25). 6923–6927. 27 indexed citations
15.
Vannucchi, Alessandro M., Paola Guglielmelli, Maria Chiara Finazzi, et al.. (2010). A Phase 1/2 Study of RAD001, a mTOR Inhibitor, In Patients with Myelofibrosis: Final Results. Blood. 116(21). 314–314. 12 indexed citations
16.
Guglielmelli, Paola, Lorenzo Tozzi, Alessandro Pancrazzi, et al.. (2007). MicroRNA expression profile in granulocytes from primary myelofibrosis patients. Experimental Hematology. 35(11). 1708.e1–1708.e12. 61 indexed citations
17.
Antonioli, Elisabetta, Paola Guglielmelli, G Poli, et al.. (2007). Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia. Haematologica. 93(1). 41–48. 119 indexed citations
18.
Tozzi, Lorenzo, Michele Bisceglia, Roberto Murgo, et al.. (2006). Male breast cancer: Our experience. Journal of Clinical Oncology. 24(18_suppl). 10733–10733. 1 indexed citations
19.
Morelli, Franco, et al.. (2006). Postchemotherapy residual masses in germ cell tumor patients: our experience. Annals of Oncology. 17. vii132–vii136. 3 indexed citations
20.
Tozzi, Lorenzo, et al.. (1999). Phase I - II Study of Oral Idarubicin, Tegafur and Levo-Folinate in Patients with Pretreated Advanced Breast Cancer. Journal of Chemotherapy. 11(5). 402–406. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026